Liquid suspension for oral administration

• US 5,156,842 A
• Filed: 09/27/1991
• Issued: 10/20/1992
• Est. Priority Date: 06/19/1987
• Status: Expired due to Term

• Current Assignee: Elan Pharma International Limited (Perrigo Company PLC)
• Original Assignee: Elan Corporation PLC (Perrigo Company PLC)
• Inventors: Mulligan, Seamus
• Primary Examiner(s): Rollins, John W.
• Application Number:
  US07/769,160
• Time in Patent Office: 389 Days
• Field of Search: 424/195.1, 424/451, 424/457, 424/439, 424/522, 424/600, 424/116, 514/558, 514/937, 514/943, 514/951, 514/964, 514/29, 514/199, 514/557
• US Class Current: 424/755
• CPC Class Codes: A61K 9/0095 Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches A61K9/0007 takes precedence; eatable gels or foams A61K9/0056; oral mucosa adhesive forms A61K9/006

Abstract

A non-aqueous pharmaceutical liquid suspension having improved bioavailability for oral administration comprises an active ingredient suspended in an edible, non-aqueous carrier vehicle such as an oil, wherein the active ingredient is in the form of controlled release particles containing the active ingredient and optionally an excipient in intimate admixture with at least one non-toxic polymer, the particles being coated with, distributed through or adsorbed onto said polymer, and the particles further having an average size in the range 0.1 to 150 microns and a predetermined release of active ingredient.

Claims

1. A non-aqueous pharmaceutical liquid suspension having improved bioavailability for oral administration comprising an antibiotic suspended in an edible, non-aqueous carrier vehicle wherein the antibiotic is in the form of controlled release microparticles containing the antibiotic and optionally an excipient, the antibiotic of said microparticles being coated with, distributed through or adsorbed onto at least one non-toxic polymer, and said microparticles further having an average size in the range 0.1 to 150 microns and a controlled rate of release of antibiotic which in combination with the non-aqueous carrier vehicle permits controlled absorption of antibiotic effective to improve the bioavailability of said antibiotic over that obtained in aqueous liquid suspensions.

2. A liquid suspension according to claim 1, wherein the non-aqueous carrier vehicle is an oil selected from the group consisting of an animal oil, a mineral and an oil of vegetable origin.

3. A liquid suspension according to claim 2, wherein the oil is an oil of vegetable origin selected from the group consisting of almond oil, arachis oil, castor oil, fractionated coconut oil, cotton seed oil, ethyl oleate oil, evening primrose oil, maize oil, olive oil, persic oil, poppy-seed oil, safflower oil, sesame oil, soya oil, sunflower oil and sucrose polyester.

4. A liquid suspension according to claim 3, wherein the oil is selected from the group consisting of fractionated coconut oil, soya oil and sunflower oil.

5. A liquid suspension according to claim 2, wherein the oil is selected from the group consisting of paraffin oil and silicone oil.

6. A liquid suspension according to claim 1, wherein the antibiotic is selected from the group consisting of a macrolide or a salt thereof and a penicillin or salt or hydrate thereof.

7. A liquid suspension according to claim 6, wherein antibiotic is Erythromycin ethyl succinate.

8. A liquid suspension according to claim 6, wherein the antibiotic is Roxithromycin.

9. A liquid suspension according to claim 6, wherein the antibiotic is Amoxicillin trihydrate.

10. A liquid suspension according to claim 1, which is in the form of capsules.